It was reported that on 29 january 2020, a 25mm epic valve was successfully implanted in a bilateral leaflet-preserving mitral valve replacement procedure.The native valve annulus was measured to be 28mm.On (b)(6) 2023, the patient presented with shortness of breath and syncope.An echocardiogram was taken, and calcification was seen.It was thought that two of the valve cusps had limited mobility, which contributed to mitral stenosis.Aortic stenosis was also observed.It was noted that posterior leaflet preservation and valve cusp fusion had occurred, as well as anterior leaflet preservation and leaflet fusion in the anterior leaflet area.On (b)(6) 2023, the epic valve was explanted, and an unknown valve was implanted as a replacement.The posterior and anterior leaflets were also sutured to treat tricuspid regurgitation (tr).Stenosis was observed on the explanted epic valve.The patient was reported as stable.
|
Explant due to stenosis was reported.The investigation found that there was fibrous pannus ingrowth on the outflow surface of cusps 1 and 2 which fused the commissure and limited the mobility of the cusps.There was outflow thrombus on cusps 1 and 3 and a thin layer of fibrous pannus on the inflow surface of cusp 1.No inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The pannus fusing cusps 1 and 2 together could have contributed to the reported stenosis.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|